Displaying 201 - 207 of 207 results
Released Company Title Industry Topic
03 Jan 2022
18:00 CET
ABIONYX PHARMA ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease 20103010 Biotechnology Other subject
06 Dec 2021
18:00 CET
ABIONYX PHARMA ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social 20103010 Biotechnology Other subject
06 Dec 2021
18:00 CET
ABIONYX PHARMA ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital 20103010 Biotechnology Other subject
06 Dec 2021
07:30 CET
ABIONYX PHARMA ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3.60 Per Share to Become a Specialist of Bioproducts... 20103010 Biotechnology Other subject
06 Dec 2021
07:30 CET
ABIONYX PHARMA ABIONYX Pharma annonce la réalisation définitive de l’apport en nature de titres Iris Pharma holding rémunéré par la remise d’actions ABIONYX Pharma au prix de 3,60€ pour devenir un spécialiste des biomédicaments en ophtalmologie... 20103010 Biotechnology Other subject
02 Dec 2021
07:36 CET
ABIONYX PHARMA ABIONYX Announces the Success of Its Capital Increase in Cash by Private Placement at a Price of €3.60 Per Share 20103010 Biotechnology Other subject
02 Dec 2021
07:36 CET
ABIONYX PHARMA ABIONYX annonce le succès de son augmentation de capital en numéraire par placement privé au prix de 3,60€ par action 20103010 Biotechnology Other subject